Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 3/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.37 |
| ▸ | BCHE | P06276 | 8/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.30 |
| ▸ | KLK1 | P06870 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7423323 | 0.93 | BCHE (0.33) | HDAC1HDAC6BCHEMEN1KMT2A | |
| SCHEMBL7424356 | 0.89 | HDAC1 (0.36) | HDAC1HDAC6BCHEKMT2A | |
| SCHEMBL7426729 | 0.83 | TP53 (0.39) | — | |
| SCHEMBL7417819 | 0.81 | HDAC1 (0.34) | HDAC1HDAC6BCHEMEN1KMT2A | |
| SCHEMBL7382337 | 0.81 | MAPT (0.41) | TDP1 | |
| SCHEMBL7429286 | 0.80 | NR4A2 (0.31) | — | |
| SCHEMBL7425444 | 0.79 | NR4A2 (0.32) | — | |
| SCHEMBL7424802 | 0.79 | ALDH1A1 (0.36) | HDAC1HDAC6 | |
| SCHEMBL1655299 | 0.76 | ATM (0.46) | — | |
| SCHEMBL7418496 | 0.76 | ADRB3 (0.33) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002039997-A2 | ACE-2 MODULATING COMPOUNDS AND USE THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2002-05-23 | — | — | WO | claimed |
| WO-2002039997-A2 | ACE-2 MODULATING COMPOUNDS AND USE THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2002-05-23 | — | — | WO | disclosed |